XML 64 R44.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2013
Fair Value Disclosures [Abstract]  
Information about Significant Unobservable Inputs used in Fair Value Measurement
The following table summarizes quantitative information about the significant unobservable inputs used in the fair value measurement of the Company’s Level III financial instruments as of December 31, 2013:
 
Valuation
 
 
 
 
 
Weighted
 
Technique
 
Unobservable Input
 
Range      
 
Average
Assets:
 
 
 
 
 
 
 
Financial instruments and other inventory positions owned:
 
 
 
 
 
 
 
Municipal securities:
 
 
 
 
 
 
 
Tax-exempt securities
Discounted cash flow
 
Debt service coverage ratio (2)
 
5 - 69%
 
22.2%
Short-term securities
Discounted cash flow
 
Expected recovery rate (% of par) (2)
 
77 - 80%
 
79.6%
Asset-backed securities:
 
 
 
 
 
 
 
Collateralized by residential mortgages
Discounted cash flow
 
Credit default rates (3)
 
2 - 8%
 
4.7%
 
 
 
Prepayment rates (4)
 
2 - 8%
 
5.3%
 
 
 
Loss severity (3)
 
52 - 100%
 
69.4%
 
 
 
Valuation yields (3)
 
4 - 8%
 
6.0%
Derivative contracts:
 
 
 
 
 
 
 
Interest rate locks
Discounted cash flow
 
Premium over the MMD curve (1)
 
3 - 49 bps
 
20.2 bps
Investments at fair value:
 
 
 
 
 
 
 
Warrants in public and private companies
Black-Scholes option pricing model
 
Liquidity discount rates (1)
 
30 - 40%
 
33.5%
Warrants in private companies
Black-Scholes option pricing model
 
Stock volatility factors of comparable companies (2)
 
28 - 97%
 
56.0%
Equity securities in private companies
Market approach
 
Revenue multiple (2)
 
2 - 7 times
 
3.2 times
 
 
 
EBITDA multiple (2)
 
12 times
 
12.0 times
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Financial instruments and other inventory positions sold, but not yet purchased:
 
 
 
 
 
 
 
Derivative contracts:
 
 
 
 
 
 
 
Interest rate locks
Discounted cash flow
 
Premium over the MMD curve (1)
 
1 - 15 bps
 
9.1 bps
Sensitivity of the fair value to changes in unobservable inputs:
(1)
Significant increase/(decrease) in the unobservable input in isolation would result in a significantly lower/(higher) fair value measurement.
(2)
Significant increase/(decrease) in the unobservable input in isolation would result in a significantly higher/(lower) fair value measurement.
(3)
Significant changes in any of these inputs in isolation could result in a significantly different fair value. Generally, a change in the assumption used for credit default rates is accompanied by a directionally similar change in the assumption used for the loss severity and a directionally inverse change in the assumption for valuation yields.
(4)
The potential impact of changes in prepayment rates on fair value is dependent on other security-specific factors, such as the par value and structure. Changes in the prepayment rates may result in directionally similar or directionally inverse changes in fair value depending on whether the security trades at a premium or discount to the par value.
Valuation of Financial Instruments by Pricing Observability Levels
The following table summarizes the valuation of the Company’s financial instruments by pricing observability levels defined in ASC 820 as of December 31, 2013:
 
 
 
 
 
 
 
Counterparty
 
 
 
 
 
 
 
 
 
and Cash
 
 
 
 
 
 
 
 
 
Collateral
 
 
(Dollars in thousands)
Level I
 
Level II
 
Level III
 
Netting (1)
 
Total
Assets:
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions owned:
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
Equity securities
$
39,711

 
$
14,386

 
$

 
$

 
$
54,097

Convertible securities

 
80,784

 

 

 
80,784

Fixed income securities

 
10,002

 
100

 

 
10,102

Municipal securities:
 
 
 
 
 
 
 
 
 
Taxable securities

 
232,379

 

 

 
232,379

Tax-exempt securities

 
459,432

 
1,433

 

 
460,865

Short-term securities

 
61,964

 
656

 

 
62,620

Asset-backed securities

 
12

 
119,799

 

 
119,811

U.S. government agency securities

 
304,737

 

 

 
304,737

Derivative contracts
19

 
351,589

 
691

 
(313,666
)
 
38,633

Total financial instruments and other inventory positions owned:
39,730

 
1,515,285

 
122,679

 
(313,666
)
 
1,364,028

 
 
 
 
 
 
 
 
 
 
Cash equivalents
101,629

 

 

 

 
101,629

 
 
 
 
 
 
 
 
 
 
Investments at fair value
20,690

 

 
49,240

 

 
69,930

Total assets
$
162,049

 
$
1,515,285

 
$
171,919

 
$
(313,666
)
 
$
1,535,587

 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions sold, but not yet purchased:
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
Equity securities
$
69,205

 
$

 
$

 
$

 
$
69,205

Fixed income securities

 
24,021

 

 

 
24,021

U.S. government agency securities

 
120,084

 

 

 
120,084

U.S. government securities
291,320

 

 

 

 
291,320

Derivative contracts
1,889

 
324,065

 
6,643

 
(324,394
)
 
8,203

Total financial instruments and other inventory positions sold, but not yet purchased:
$
362,414

 
$
468,170

 
$
6,643

 
$
(324,394
)
 
$
512,833

(1)
Represents cash collateral and the impact of netting on a counterparty basis. The Company had no securities posted as collateral to its counterparties.

The following table summarizes the valuation of the Company’s financial instruments by pricing observability levels defined in ASC 820 as of December 31, 2012:
 
 
 
 
 
 
 
Counterparty
 
 
 
 
 
 
 
 
 
and Cash
 
 
 
 
 
 
 
 
 
Collateral
 
 
(Dollars in thousands)
Level I
 
Level II
 
Level III
 
Netting (1)
 
Total
Assets:
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions owned:
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
Equity securities
$
3,180

 
$
13,298

 
$

 
$

 
$
16,478

Convertible securities

 
44,978

 

 

 
44,978

Fixed income securities

 
33,668

 

 

 
33,668

Municipal securities:
 
 
 
 
 
 
 
 
 
Taxable securities

 
164,059

 

 

 
164,059

Tax-exempt securities

 
416,760

 
1,429

 

 
418,189

Short-term securities

 
67,672

 
656

 

 
68,328

Asset-backed securities

 
24

 
116,171

 

 
116,195

U.S. government agency securities

 
304,259

 

 

 
304,259

U.S. government securities
4,966

 

 

 

 
4,966

Derivative contracts

 
595,486

 
827

 
(555,838
)
 
40,475

Total financial instruments and other inventory positions owned:
8,146

 
1,640,204

 
119,083

 
(555,838
)
 
1,211,595

 
 
 
 
 
 
 
 
 
 
Cash equivalents
51,346

 

 

 

 
51,346

 
 
 
 
 
 
 
 
 
 
Investments at fair value
5,810

 

 
33,245

 

 
39,055

Total assets
$
65,302

 
$
1,640,204

 
$
152,328

 
$
(555,838
)
 
$
1,301,996

 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions sold, but not yet purchased:
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
Equity securities
$
25,362

 
$
1,728

 
$

 
$

 
$
27,090

Convertible securities

 
1,015

 

 

 
1,015

Fixed income securities

 
19,314

 

 

 
19,314

Municipal securities:
 
 
 
 
 
 
 
 


Short-term securities

 
60

 

 

 
60

U.S. government agency securities

 
73,724

 

 

 
73,724

U.S. government securities
231,043

 

 

 

 
231,043

Derivative contracts

 
569,764

 
5,218

 
(570,027
)
 
4,955

Total financial instruments and other inventory positions sold, but not yet purchased:
$
256,405

 
$
665,605

 
$
5,218

 
$
(570,027
)
 
$
357,201

(1)
Represents cash collateral and the impact of netting on a counterparty basis. The Company had no securities posted as collateral to its counterparties.
Changes in Fair Value Associated with Level III Financial Instruments
The following tables summarize the changes in fair value associated with Level III financial instruments during the years ended December 31, 2013 and 2012:
 
Balance at
 
 
 
 
 
 
 
 
 
Realized
 
Unrealized
 
Balance at
 
December 31,
 
 
 
 
 
Transfers
 
Transfers
 
gains/
 
gains/
 
December 31,
(Dollars in thousands)
2012
 
Purchases
 
Sales
 
in
 
out
 
(losses) (1)
 
(losses) (1)
 
2013
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions owned:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed income securities
$

 
$
100

 
$

 
$

 
$

 
$

 
$

 
$
100

Municipal securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tax-exempt securities
1,429

 
1

 

 

 

 

 
3

 
1,433

Short-term securities
656

 

 

 

 

 

 

 
656

Asset-backed securities
116,171

 
227,634

 
(238,860
)
 

 

 
17,105

 
(2,251
)
 
119,799

Derivative contracts
827

 
5

 
(2,382
)
 

 

 
2,377

 
(136
)
 
691

Total financial instruments and other inventory positions owned:
119,083

 
227,740

 
(241,242
)
 

 

 
19,482

 
(2,384
)
 
122,679

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments at fair value
33,245

 
16,825

 
(10,358
)
 

 
(619
)
 
5,949

 
4,198

 
49,240

Total assets
$
152,328

 
$
244,565

 
$
(251,600
)
 
$

 
$
(619
)
 
$
25,431

 
$
1,814

 
$
171,919

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions sold, but not yet purchased:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Derivative contracts
$
5,218

 
$
(5,702
)
 
$
457

 
$

 
$

 
$
5,232

 
$
1,438

 
$
6,643

Total financial instruments and other inventory positions sold, but not yet purchased:
$
5,218

 
$
(5,702
)
 
$
457

 
$

 
$

 
$
5,232

 
$
1,438

 
$
6,643

(1)
Realized and unrealized gains/(losses) related to financial instruments, with the exception of customer matched-book derivatives, are reported in institutional brokerage on the consolidated statements of operations. Realized and unrealized gains/(losses) related to customer matched-book derivatives are reported in investment banking. Realized and unrealized gains/(losses) related to investments are reported in investment banking revenues or investment income on the consolidated statements of operations.
 
Balance at
 
 
 
 
 
 
 
 
 
Realized
 
Unrealized
 
Balance at
 
December 31,
 
 
 
 
 
Transfers
 
Transfers
 
gains/
 
gains/
 
December 31,
(Dollars in thousands)
2011
 
Purchases
 
Sales
 
in
 
out
 
(losses) (1)
 
(losses) (1)
 
2012
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions owned:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed income securities
$
2,815

 
$
1,995

 
$
(4,594
)
 
$

 
$

 
$
(118
)
 
$
(98
)
 
$

Municipal securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Tax-exempt securities
3,135

 
1,550

 
(2,997
)
 
266

 

 
(1,156
)
 
631

 
1,429

Short-term securities
175

 
650

 

 

 

 

 
(169
)
 
656

Asset-backed securities
53,088

 
125,844

 
(69,623
)
 
38

 

 
487

 
6,337

 
116,171

Derivative contracts

 

 

 

 

 

 
827

 
827

Total financial instruments and other inventory positions owned:
59,213

 
130,039

 
(77,214
)
 
304

 

 
(787
)
 
7,528

 
119,083

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments at fair value
21,341

 
15,003

 
(2,394
)
 

 
(266
)
 
1,595

 
(2,034
)
 
33,245

Total assets
$
80,554

 
$
145,042

 
$
(79,608
)
 
$
304

 
$
(266
)
 
$
808

 
$
5,494

 
$
152,328

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial instruments and other inventory positions sold, but not yet purchased:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate securities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Convertible securities
$
1,171

 
$

 
$

 
$

 
$
(1,171
)
 
$

 
$

 
$

Fixed income securities
900

 
(897
)
 

 

 

 
(49
)
 
46

 

Derivative contracts
3,594

 
(6,549
)
 

 

 

 
6,549

 
1,624

 
5,218

Total financial instruments and other inventory positions sold, but not yet purchased:
$
5,665

 
$
(7,446
)
 
$

 
$

 
$
(1,171
)
 
$
6,500

 
$
1,670

 
$
5,218

(1)
Realized and unrealized gains/(losses) related to financial instruments, with the exception of customer matched-book derivatives, are reported in institutional brokerage on the consolidated statements of operations. Realized and unrealized gains/(losses) related to customer matched-book derivatives are reported in investment banking. Realized and unrealized gains/(losses) related to investments are reported in investment banking revenues or investment income on the consolidated statements of operations